Coinbase CEO-Backed NewLimit Claims Aging Reversal Breakthrough, Raises $435 Million For Human Trials
Coinbase COIN | 0.00 |
Coinbase Global Inc. (NASDAQ:COIN) CEO Brian Armstrong backed biotechnology startup NewLimit, which says it has developed an experimental drug that can partially reverse signs of aging in human cells and is preparing to begin its first human clinical trials next year.
Cellular Aging Breakthrough Claims
On Tuesday, NewLimit, a longevity-focused biotech company co-founded by Armstrong, announced that its research has produced a prototype therapy that "reverses the age of some human cells" and restores certain functions associated with younger biological states.
"Aging is arguably the root cause of most major diseases," Armstrong said in a post on X while sharing the company's update.
"Four years ago, we made a bet that aging was treatable, and NewLimit was born," he added.
The company also said it has raised a $435 million in a Series C funding round led by Founders Fund to advance its research and move toward clinical testing.
NewLimit stated in its announcement that "reprogramming cell age has the potential to create more healthy years for everyone," adding that it is now "closer than ever" to bringing longevity medicine into human trials.
The startup said it has additional drug candidates in its pipeline and is working with researchers to validate early findings before initiating studies in humans next year.
Musk, Johnson Debate Aging Claims
Earlier, Elon Musk said human death was "pre-programmed" and described aging as a biological system that could potentially be engineered, suggesting life extension depended on identifying the body's internal "clock."
He argued that aging was synchronized across the body and said it may be less complex to solve than commonly believed.
Separately, Bryan Johnson rejected claims that Ozempic had anti-aging effects, saying existing data did not support the conclusion.
He argued that study results showing "age reversal" were likely due to fat loss and improved metabolic health, not a direct impact on biological aging.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock By Thrive Studios ID